These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38640065)

  • 1. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for generating in-frame seamless knockins in Drosophila using the SEED/Harvest technology.
    Aguilar G; Bauer M; Vigano MA; Guerrero I; Affolter M
    STAR Protoc; 2024 Sep; 5(3):102932. PubMed ID: 38996063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for establishing knockout cell clones by deletion of a large gene fragment using CRISPR-Cas9 with multiple guide RNAs.
    Saito AC; Higashi T; Chiba H
    STAR Protoc; 2024 Sep; 5(3):103179. PubMed ID: 38972040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Mutations in the Mouse via Embryonic Stem Cells.
    Gertsenstein M; Mianné J; Teboul L; Nutter LMJ
    Methods Mol Biol; 2020; 2066():59-82. PubMed ID: 31512207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells.
    Tran NT; Trombke J; Rajewsky K; Chu VT
    STAR Protoc; 2020 Jun; 1(1):100028. PubMed ID: 32685932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Large Fragment Knock-In Mouse Models by Microinjecting into 2-Cell Stage Embryos.
    Gu B; Gertsenstein M; Posfai E
    Methods Mol Biol; 2020; 2066():89-100. PubMed ID: 31512209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the CRISPR-Cas9 System in Drosophila Cultured Cells to Introduce Fluorescent Tags into Endogenous Genes.
    Bosch JA; Knight S; Kanca O; Zirin J; Yang-Zhou D; Hu Y; Rodiger J; Amador G; Bellen HJ; Perrimon N; Mohr SE
    Curr Protoc Mol Biol; 2020 Mar; 130(1):e112. PubMed ID: 31869524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creation of zebrafish knock-in reporter lines in the nefma gene by Cas9-mediated homologous recombination.
    Eschstruth A; Schneider-Maunoury S; Giudicelli F
    Genesis; 2020 Jan; 58(1):e23340. PubMed ID: 31571409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.
    Vazquez N; Sanchez L; Marks R; Martinez E; Fanniel V; Lopez A; Salinas A; Flores I; Hirschmann J; Gilkerson R; Schuenzel E; Dearth R; Halaby R; Innis-Whitehouse W; Keniry M
    BMC Mol Biol; 2018 Mar; 19(1):3. PubMed ID: 29540148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs.
    Laustsen A; Bak RO
    Methods Mol Biol; 2019; 1961():127-134. PubMed ID: 30912044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System.
    Xue H; Wu J; Li S; Rao MS; Liu Y
    Methods Mol Biol; 2016; 1307():173-90. PubMed ID: 24615461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation.
    Papasavva PL; Patsali P; Loucari CC; Kurita R; Nakamura Y; Kleanthous M; Lederer CW
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simple and Efficient Procedure for Developing Mouse Germline Stem Cell Lines with Gene Knock-in via CRISPR/Cas9 Technology.
    Wang Y; Hu S; Han C
    Curr Protoc; 2024 Sep; 4(9):e70002. PubMed ID: 39264143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected genomic rearrangements at targeted loci associated with CRISPR/Cas9-mediated knock-in.
    Rezza A; Jacquet C; Le Pillouer A; Lafarguette F; Ruptier C; Billandon M; Isnard Petit P; Trouttet S; Thiam K; Fraichard A; Chérifi Y
    Sci Rep; 2019 Mar; 9(1):3486. PubMed ID: 30837594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
    El Marjou F; Jouhanneau C; Krndija D
    Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.